HYPOPARATHYROIDISM
Clinical trials for HYPOPARATHYROIDISM explained in plain language.
Never miss a new study
Get alerted when new HYPOPARATHYROIDISM trials appear
Sign up with your email to follow new studies for HYPOPARATHYROIDISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Long-Term control of rare hormone disorder
Disease control OngoingThis study looks at the long-term safety of a weekly injection called MBX 2109 for people with hypoparathyroidism, a condition where the body doesn't produce enough parathyroid hormone. Participants are adults who already completed a 12-week treatment in an earlier study. The goa…
Matched conditions: HYPOPARATHYROIDISM
Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New registry tracks Real-World outcomes for hypoparathyroidism treatment
Knowledge-focused OngoingThis study is a registry that collects information on the long-term safety and effectiveness of a medication called rhPTH(1-84) for people with chronic hypoparathyroidism. Participants receive their usual care from their doctors and fill out questionnaires during routine visits. …
Matched conditions: HYPOPARATHYROIDISM
Sponsor: Takeda • Aim: Knowledge-focused
Last updated May 17, 2026 07:58 UTC